Daniel L. Marks - Publications

2008-2013 Pediatric Endocrinology Oregon Health&Science University, Portland, OR, United States 

106 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Korzun T, Moses AS, Kim J, Patel S, Schumann C, Levasseur PR, Diba P, Olson B, Rebola KGO, Norgard M, Park Y, Demessie AA, Eygeris Y, Grigoriev V, Sundaram S, ... ... Marks DL, et al. Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia. Small (Weinheim An Der Bergstrasse, Germany). e2204436. PMID 36098251 DOI: 10.1002/smll.202204436  0.784
2022 Gunesch AN, Sutton TL, Krasnow SM, Deig CR, Sheppard BC, Marks DL, Grossberg AJ. Validation of automated body composition analysis using diagnostic computed tomography imaging in patients with pancreatic cancer. American Journal of Surgery. PMID 35396132 DOI: 10.1016/j.amjsurg.2022.03.025  0.757
2022 Huisman C, Norgard MA, Levasseur PR, Krasnow SM, van der Wijst MGP, Olson B, Marks DL. Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing. Molecular Metabolism. 101441. PMID 35031523 DOI: 10.1016/j.molmet.2022.101441  0.72
2021 Olson B, Diba P, Korzun T, Marks DL. Neural Mechanisms of Cancer Cachexia. Cancers. 13. PMID 34439145 DOI: 10.3390/cancers13163990  0.743
2021 Olson B, Zhu X, Norgard MA, Levasseur PR, Butler JT, Buenafe A, Burfeind KG, Michaelis KA, Pelz KR, Mendez H, Edwards J, Krasnow SM, Grossberg AJ, Marks DL. Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia. Nature Communications. 12: 2057. PMID 33824339 DOI: 10.1038/s41467-021-22361-3  0.783
2020 Olson B, Marks DL, Grossberg AJ. Diverging metabolic programmes and behaviours during states of starvation, protein malnutrition, and cachexia. Journal of Cachexia, Sarcopenia and Muscle. PMID 32985801 DOI: 10.1002/jcsm.12630  0.587
2020 Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, Marks DL, Mehta A, Nabavizadeh N, Simeone DM, Weekes CD, Thomas CR. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. Ca: a Cancer Journal For Clinicians. PMID 32683683 DOI: 10.3322/Caac.21626  0.641
2020 Zhu X, Callahan MF, Gruber KA, Szumowski M, Marks DL. Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia. The Journal of Clinical Investigation. PMID 32544087 DOI: 10.1172/Jci138392  0.401
2020 Shi Z, Pelletier NE, Wong J, Li B, Sdrulla AD, Madden CJ, Marks DL, Brooks VL. Leptin increases sympathetic nerve activity via induction of its own receptor in the paraventricular nucleus. Elife. 9. PMID 32538782 DOI: 10.7554/Elife.55357  0.353
2020 Olson B, Edwards J, Stone L, Jiang A, Zhu X, Holland J, Li R, Andersen P, Krasnow S, Marks DL, Clayburgh D. Association of Sarcopenia With Oncologic Outcomes of Primary Surgery or Definitive Radiotherapy Among Patients With Localized Oropharyngeal Squamous Cell Carcinoma. Jama Otolaryngology-- Head & Neck Surgery. PMID 32525518 DOI: 10.1001/Jamaoto.2020.1154  0.692
2020 Burfeind KG, Zhu X, Norgard MA, Levasseur PR, Huisman C, Buenafe AC, Olson B, Michaelis KA, Torres ERS, Jeng S, McWeeney S, Raber J, Marks DL. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer. Elife. 9. PMID 32391790 DOI: 10.7554/Elife.54095  0.345
2020 Burfeind KG, Zhu X, Norgard MA, Levasseur PR, Huisman C, Michaelis KA, Olson B, Marks DL. Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic cancer. Glia. PMID 32039522 DOI: 10.1002/Glia.23796  0.402
2020 Burfeind KG, Zhu X, Norgard MA, Levasseur PR, Huisman C, Buenafe AC, Olson B, Michaelis KA, Torres ER, Jeng S, McWeeney S, Raber J, Marks DL. Author response: Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer Elife. DOI: 10.7554/Elife.54095.Sa2  0.325
2019 Michaelis KA, Norgard MA, Zhu X, Levasseur PR, Sivagnanam S, Liudahl SM, Burfeind KG, Olson B, Pelz KR, Angeles Ramos DM, Maurer HC, Olive KP, Coussens LM, Morgan TK, Marks DL. The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Nature Communications. 10: 4682. PMID 31615993 DOI: 10.1038/S41467-019-12657-W  0.312
2019 Michaelis KA, Norgard MA, Levasseur PR, Olson B, Burfeind KG, Buenafe AC, Zhu X, Jeng S, McWeeney SK, Marks DL. Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance. Brain, Behavior, and Immunity. PMID 31499172 DOI: 10.1016/J.Bbi.2019.09.004  0.312
2019 Stone L, Olson B, Mowery A, Krasnow S, Jiang A, Li R, Schindler J, Wax MK, Andersen P, Marks D, Achim V, Clayburgh D. Association Between Sarcopenia and Mortality in Patients Undergoing Surgical Excision of Head and Neck Cancer. Jama Otolaryngology-- Head & Neck Surgery. PMID 31169874 DOI: 10.1001/Jamaoto.2019.1185  0.709
2019 Doslikova B, Tchir D, McKinty A, Zhu X, Marks DL, Baracos VE, Colmers WF. Convergent neuronal projections from paraventricular nucleus, parabrachial nucleus and brainstem onto gastrocnemius muscle, white and brown adipose tissue in male rats. The Journal of Comparative Neurology. PMID 31045239 DOI: 10.1002/Cne.24710  0.351
2019 Zhu X, Burfeind KG, Michaelis KA, Braun TP, Olson B, Pelz KR, Morgan TK, Marks DL. MyD88 signalling is critical in the development of pancreatic cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle. PMID 30666818 DOI: 10.1002/Jcsm.12377  0.356
2018 Schumann C, Nguyen DX, Norgard M, Bortnyak Y, Korzun T, Chan S, Lorenz AS, Moses AS, Albarqi HA, Wong L, Michaelis K, Zhu X, Alani AWG, Taratula OR, Krasnow S, ... Marks DL, et al. Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA. Theranostics. 8: 5276-5288. PMID 30555546 DOI: 10.7150/Thno.27847  0.762
2018 Girardet C, Marks DL, Butler AA. Melanocortin-3 Receptors Expressed on Agouti-Related Peptide Neurons Inhibit Feeding Behavior in Female Mice. Obesity (Silver Spring, Md.). 26: 1849-1855. PMID 30426710 DOI: 10.1002/Oby.22306  0.319
2018 Krzysiak TC, Thomas L, Choi YJ, Auclair S, Qian Y, Luan S, Krasnow SM, Thomas LL, Koharudin LMI, Benos PV, Marks DL, Gronenborn AM, Thomas G. An Insulin-Responsive Sensor in the SIRT1 Disordered Region Binds DBC1 and PACS-2 to Control Enzyme Activity. Molecular Cell. PMID 30415949 DOI: 10.1016/J.Molcel.2018.10.007  0.683
2018 Burfeind KG, Zhu X, Levasseur PR, Michaelis KA, Norgard MA, Marks DL. "TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia". Brain, Behavior, and Immunity. PMID 29852290 DOI: 10.1016/J.Bbi.2018.05.021  0.359
2018 Michaelis KA, Norgard MA, Zhu X, Levasseur PR, Pelz KR, Burfeind KG, Morgan TK, Marks DL. Abstract 3779: The TLR7/8 agonist R848 induces antitumor responses and attenuates cachexia in a murine model of pancreatic ductal adenocarcinoma Cancer Research. 78: 3779-3779. DOI: 10.1158/1538-7445.Am2018-3779  0.367
2017 Gabriel Knoll J, Krasnow SM, Marks DL. Interleukin-1β signaling in fenestrated capillaries is sufficient to trigger sickness responses in mice. Journal of Neuroinflammation. 14: 219. PMID 29121947 DOI: 10.1186/S12974-017-0990-7  0.708
2017 Michaelis KA, Zhu X, Burfeind KG, Krasnow SM, Levasseur PR, Morgan TK, Marks DL. Establishment and characterization of a novel murine model of pancreatic cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle. PMID 28730707 DOI: 10.1002/Jcsm.12225  0.706
2017 Krasnow SM, Knoll JG, Verghese SC, Levasseur PR, Marks DL. Amplification and propagation of interleukin-1β signaling by murine brain endothelial and glial cells. Journal of Neuroinflammation. 14: 133. PMID 28668091 DOI: 10.1186/S12974-017-0908-4  0.689
2017 Butler AA, Girardet C, Mavrikaki M, Trevaskis JL, Macarthur H, Marks DL, Farr SA. A Life without Hunger: The Ups (and Downs) to Modulating Melanocortin-3 Receptor Signaling. Frontiers in Neuroscience. 11: 128. PMID 28360832 DOI: 10.3389/Fnins.2017.00128  0.382
2017 Girardet C, Mavrikaki MM, Stevens JR, Miller CA, Marks DL, Butler AA. Melanocortin-3 receptors expressed in Nkx2.1(+ve) neurons are sufficient for controlling appetitive responses to hypocaloric conditioning. Scientific Reports. 7: 44444. PMID 28294152 DOI: 10.1038/Srep44444  0.337
2017 Goloviznina NA, Verghese SC, Yoon YM, Taratula O, Marks DL, Kurre P. Mesenchymal stromal cell-derived extracellular vesicles promote myeloid-biased multipotent hematopoietic progenitor expansion via Toll-like receptor engagement. The Journal of Biological Chemistry. 292: 3541. PMID 28235900 DOI: 10.1074/jbc.A116.745653  0.554
2016 Kram DE, Krasnow SM, Levasseur PR, Zhu X, Stork LC, Marks DL. Dexamethasone Chemotherapy Does Not Disrupt Orexin Signaling. Plos One. 11: e0168731. PMID 27997622 DOI: 10.1371/Journal.Pone.0168731  0.69
2016 Goloviznina NA, Verghese SC, Yoon YM, Taratula O, Marks DL, Kurre P. Mesenchymal Stromal Cell Derived Extracellular Vesicles Promote Myeloid Biased Multipotent Hematopoietic Progenitor Expansion via Toll-Like Receptor Engagement. The Journal of Biological Chemistry. PMID 27758863 DOI: 10.1074/Jbc.M116.745653  0.611
2016 Daniel JA, Whitlock BK, Marks DL, Gard JA, Sartin JL. Leukemia inhibitory factor as a mediator of lipopolysaccharide effects on appetite and selected hormones and metabolites. Journal of Animal Science. 94: 2789-97. PMID 27482666 DOI: 10.2527/Jas.2016-0396  0.312
2016 Mavrikaki M, Girardet C, Kern A, Faruzzi Brantley A, Miller CA, Macarthur H, Marks DL, Butler AA. Melanocortin-3 receptors in the limbic system mediate feeding-related motivational responses during weight loss. Molecular Metabolism. 5: 566-79. PMID 27408780 DOI: 10.1016/J.Molmet.2016.05.002  0.335
2015 Tian Q, Smart JL, Clement JH, Wang Y, Derkatch A, Schubert H, Danilchik MV, Marks DL, Fedorov LM. RHEB1 expression in embryonic and postnatal mouse. Histochemistry and Cell Biology. PMID 26708151 DOI: 10.1007/S00418-015-1394-3  0.304
2015 Burfeind K, Michaelis KA, Marks DL. The central role of hypothalamic inflammation in the acute illness response and cachexia. Seminars in Cell & Developmental Biology. PMID 26541482 DOI: 10.1016/J.Semcdb.2015.10.038  0.376
2015 Luchtman DW, Chee MJ, Doslikova B, Marks DL, Baracos VE, Colmers WF. Defense of Elevated Body Weight Setpoint in Diet-Induced Obese Rats on Low Energy Diet Is Mediated by Loss of Melanocortin Sensitivity in the Paraventricular Hypothalamic Nucleus. Plos One. 10: e0139462. PMID 26444289 DOI: 10.1371/Journal.Pone.0139462  0.309
2015 Dwarkasing JT, Marks DL, Witkamp RF, van Norren K. Hypothalamic inflammation and food intake regulation during chronic illness. Peptides. PMID 26158772 DOI: 10.1016/J.Peptides.2015.06.011  0.302
2015 Braun TP, Marks DL. The regulation of muscle mass by endogenous glucocorticoids. Frontiers in Physiology. 6: 12. PMID 25691871 DOI: 10.3389/Fphys.2015.00012  0.368
2015 Kamimae-Lanning AN, Krasnow SM, Goloviznina NA, Zhu X, Roth-Carter QR, Levasseur PR, Jeng S, McWeeney SK, Kurre P, Marks DL. Maternal high-fat diet and obesity compromise fetal hematopoiesis. Molecular Metabolism. 4: 25-38. PMID 25685687 DOI: 10.1016/J.Molmet.2014.11.001  0.7
2014 Braun TP, Szumowski M, Levasseur PR, Grossberg AJ, Zhu X, Agarwal A, Marks DL. Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle. Plos One. 9: e106489. PMID 25254959 DOI: 10.1371/Journal.Pone.0106489  0.685
2014 Zuloaga KL, Krasnow SM, Zhu X, Zhang W, Jouihan SA, Shangraw RE, Alkayed NJ, Marks DL. Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke. Plos One. 9: e97529. PMID 24824753 DOI: 10.1371/Journal.Pone.0097529  0.696
2014 Weymann KB, Wood LJ, Zhu X, Marks DL. A role for orexin in cytotoxic chemotherapy-induced fatigue. Brain, Behavior, and Immunity. 37: 84-94. PMID 24216337 DOI: 10.1016/J.Bbi.2013.11.003  0.721
2014 Kamimae-Lanning AN, Goloviznina NA, Krasnow SM, Marks DL, Kurre P. Metabolic Programming of the Fetal Liver Hematopoietic Stem and Progenitor Cell Pool Blood. 124: 4315-4315. DOI: 10.1182/Blood.V124.21.4315.4315  0.709
2013 Jouihan SA, Zuloaga KL, Zhang W, Shangraw RE, Krasnow SM, Marks DL, Alkayed NJ. Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1650-6. PMID 23899929 DOI: 10.1038/Jcbfm.2013.130  0.698
2013 Braun TP, Grossberg AJ, Krasnow SM, Levasseur PR, Szumowski M, Zhu XX, Maxson JE, Knoll JG, Barnes AP, Marks DL. Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 3572-82. PMID 23733748 DOI: 10.1096/Fj.13-230375  0.784
2013 Nicol LE, Grant WF, Grant WR, Comstock SM, Nguyen ML, Smith MS, Grove KL, Marks DL. Pancreatic inflammation and increased islet macrophages in insulin-resistant juvenile primates. The Journal of Endocrinology. 217: 207-13. PMID 23420316 DOI: 10.1530/Joe-12-0424  0.313
2013 Braun T, Krasnow S, Levasseur P, Grossberg A, Szumowski M, Maxson J, Barnes A, Marks D. Glucocorticoid Signaling in Skeletal Muscle Is Critical for Cancer and Endotoxin-Induced Cachexia International Journal of Radiation Oncology*Biology*Physics. 87: S635. DOI: 10.1016/J.Ijrobp.2013.06.1678  0.776
2012 Zhu X, Krasnow SM, Roth-Carter QR, Levasseur PR, Braun TP, Grossberg AJ, Marks DL. Hypothalamic signaling in anorexia induced by indispensable amino acid deficiency. American Journal of Physiology. Endocrinology and Metabolism. 303: E1446-58. PMID 23047987 DOI: 10.1152/Ajpendo.00427.2012  0.784
2012 Braun TP, Grossberg AJ, Veleva-Rotse BO, Maxson JE, Szumowski M, Barnes AP, Marks DL. Expression of myeloid differentiation factor 88 in neurons is not requisite for the induction of sickness behavior by interleukin-1β. Journal of Neuroinflammation. 9: 229. PMID 23031643 DOI: 10.1186/1742-2094-9-229  0.661
2012 Braun TP, Orwoll B, Zhu X, Levasseur PR, Szumowski M, Nguyen ML, Bouxsein ML, Klein RF, Marks DL. Regulation of lean mass, bone mass, and exercise tolerance by the central melanocortin system. Plos One. 7: e42183. PMID 22848742 DOI: 10.1371/Journal.Pone.0042183  0.319
2012 Tan BH, Fladvad T, Braun TP, Vigano A, Strasser F, Deans DA, Skipworth RJ, Solheim TS, Damaraju S, Ross JA, Kaasa S, Marks DL, Baracos VE, Skorpen F, Fearon KC, et al. P-selectin genotype is associated with the development of cancer cachexia. Embo Molecular Medicine. 4: 462-71. PMID 22473907 DOI: 10.1002/Emmm.201200231  0.318
2011 Braun TP, Zhu X, Szumowski M, Scott GD, Grossberg AJ, Levasseur PR, Graham K, Khan S, Damaraju S, Colmers WF, Baracos VE, Marks DL. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. The Journal of Experimental Medicine. 208: 2449-63. PMID 22084407 DOI: 10.1084/Jem.20111020  0.667
2011 Begriche K, Levasseur PR, Zhang J, Rossi J, Skorupa D, Solt LA, Young B, Burris TP, Marks DL, Mynatt RL, Butler AA. Genetic dissection of the functions of the melanocortin-3 receptor, a seven-transmembrane G-protein-coupled receptor, suggests roles for central and peripheral receptors in energy homeostasis. The Journal of Biological Chemistry. 286: 40771-81. PMID 21984834 DOI: 10.1074/Jbc.M111.278374  0.372
2011 Dallmann R, Weyermann P, Anklin C, Boroff M, Bray-French K, Cardel B, Courdier-Fruh I, Deppe H, Dubach-Powell J, Erb M, Haefeli RH, Henneböhle M, Herzner H, Hufschmid M, Marks DL, et al. The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle. 2: 163-174. PMID 21966642 DOI: 10.1007/S13539-011-0039-1  0.31
2011 Krasnow SM, Nguyen ML, Marks DL. Increased maternal fat consumption during pregnancy alters body composition in neonatal mice. American Journal of Physiology. Endocrinology and Metabolism. 301: E1243-53. PMID 21900122 DOI: 10.1152/Ajpendo.00261.2011  0.707
2011 Grossberg AJ, Zhu X, Leinninger GM, Levasseur PR, Braun TP, Myers MG, Marks DL. Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 11376-86. PMID 21813697 DOI: 10.1523/Jneurosci.2311-11.2011  0.661
2011 Braun TP, Marks DL. Hypothalamic regulation of muscle metabolism. Current Opinion in Clinical Nutrition and Metabolic Care. 14: 237-42. PMID 21502918 DOI: 10.1097/Mco.0B013E328345Bbcd  0.351
2011 Sampath H, Batra AK, Vartanian V, Carmical JR, Prusak D, King IB, Lowell B, Earley LF, Wood TG, Marks DL, McCullough AK, R Stephen L. Variable penetrance of metabolic phenotypes and development of high-fat diet-induced adiposity in NEIL1-deficient mice. American Journal of Physiology. Endocrinology and Metabolism. 300: E724-34. PMID 21285402 DOI: 10.1152/Ajpendo.00387.2010  0.325
2010 Braun TP, Marks DL. Pathophysiology and treatment of inflammatory anorexia in chronic disease. Journal of Cachexia, Sarcopenia and Muscle. 1: 135-145. PMID 21475703 DOI: 10.1007/S13539-010-0015-1  0.323
2010 Krasnow SM, Marks DL. Neuropeptides in the pathophysiology and treatment of cachexia. Current Opinion in Supportive and Palliative Care. 4: 266-71. PMID 20733497 DOI: 10.1097/Spc.0B013E32833E48E7  0.721
2010 Scarlett JM, Bowe DD, Zhu X, Batra AK, Grant WF, Marks DL. Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure. The Journal of Endocrinology. 206: 121-30. PMID 20371568 DOI: 10.1677/Joe-09-0397  0.319
2010 Grossberg AJ, Scarlett JM, Marks DL. Hypothalamic mechanisms in cachexia. Physiology & Behavior. 100: 478-89. PMID 20346963 DOI: 10.1016/J.Physbeh.2010.03.011  0.665
2010 Grayson BE, Levasseur PR, Williams SM, Smith MS, Marks DL, Grove KL. Changes in melanocortin expression and inflammatory pathways in fetal offspring of nonhuman primates fed a high-fat diet. Endocrinology. 151: 1622-32. PMID 20176722 DOI: 10.1210/En.2009-1019  0.339
2010 Grossberg AJ, Scarlett JM, Zhu X, Bowe DD, Batra AK, Braun TP, Marks DL. Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130. Endocrinology. 151: 606-16. PMID 20016025 DOI: 10.1210/En.2009-1135  0.657
2010 Barazzoni R, Zhu X, Deboer M, Datta R, Culler MD, Zanetti M, Guarnieri G, Marks DL. Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease. Kidney International. 77: 23-8. PMID 19890275 DOI: 10.1038/Ki.2009.411  0.338
2009 Austin J, Marks D. Hormonal regulators of appetite. International Journal of Pediatric Endocrinology. 2009: 141753. PMID 19946401 DOI: 10.1155/2009/141753  0.309
2009 DeBoer MD, Scarlett JM, Levasseur PR, Grant WF, Marks DL. Administration of IL-1beta to the 4th ventricle causes anorexia that is blocked by agouti-related peptide and that coincides with activation of tyrosine-hydroxylase neurons in the nucleus of the solitary tract. Peptides. 30: 210-8. PMID 19028534 DOI: 10.1016/J.Peptides.2008.10.019  0.303
2008 Laviano A, Inui A, Marks DL, Meguid MM, Pichard C, Rossi Fanelli F, Seelaender M. Neural control of the anorexia-cachexia syndrome. American Journal of Physiology. Endocrinology and Metabolism. 295: E1000-8. PMID 18713954 DOI: 10.1152/Ajpendo.90252.2008  0.347
2008 Scarlett JM, Zhu X, Enriori PJ, Bowe DD, Batra AK, Levasseur PR, Grant WF, Meguid MM, Cowley MA, Marks DL. Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation. Endocrinology. 149: 4837-45. PMID 18583425 DOI: 10.1210/En.2007-1680  0.361
2008 Sartin JL, Marks DL, McMahon CD, Daniel JA, Levasseur P, Wagner CG, Whitlock BK, Steele BP. Central role of the melanocortin-4 receptors in appetite regulation after endotoxin. Journal of Animal Science. 86: 2557-67. PMID 18502874 DOI: 10.2527/Jas.2008-0916  0.304
2008 Madison LD, Scarlett JM, Levasseur P, Zhu X, Newcomb K, Batra A, Bowe D, Marks DL. Prostacyclin signaling regulates circulating ghrelin during acute inflammation. The Journal of Endocrinology. 196: 263-73. PMID 18252949 DOI: 10.1677/Joe-07-0478  0.33
2008 Deboer MD, Zhu X, Levasseur PR, Inui A, Hu Z, Han G, Mitch WE, Taylor JE, Halem HA, Dong JZ, Datta R, Culler MD, Marks DL. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology. 149: 827-35. PMID 18039782 DOI: 10.1210/En.2007-1046  0.388
2007 Ellacott KL, Murphy JG, Marks DL, Cone RD. Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. Endocrinology. 148: 6186-94. PMID 17901224 DOI: 10.1210/En.2007-0699  0.344
2007 Cheung WW, Kuo HJ, Markison S, Chen C, Foster AC, Marks DL, Mak RH. Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. Journal of the American Society of Nephrology : Jasn. 18: 2517-24. PMID 17687077 DOI: 10.1681/Asn.2006091024  0.349
2007 Scarlett JM, Jobst EE, Enriori PJ, Bowe DD, Batra AK, Grant WF, Cowley MA, Marks DL. Regulation of central melanocortin signaling by interleukin-1 beta. Endocrinology. 148: 4217-25. PMID 17525125 DOI: 10.1210/En.2007-0017  0.308
2007 DeBoer MD, Zhu XX, Levasseur P, Meguid MM, Suzuki S, Inui A, Taylor JE, Halem HA, Dong JZ, Datta R, Culler MD, Marks DL. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology. 148: 3004-12. PMID 17347304 DOI: 10.1210/En.2007-0016  0.348
2007 Bowe DD, Scarlett JM, Batra AK, Steiner RA, Marks DL. BLOCKADE OF CENTRAL MELANOCORTIN SIGNALING PROMOTES ACCUMULATION OF LEAN BODY MASS IN RODENT MODELS OF CHRONIC HEART FAILURE. Journal of Investigative Medicine. 55: S77. DOI: 10.1097/00042871-200701010-00018  0.481
2006 Mak RH, Cheung W, Cone RD, Marks DL. Mechanisms of disease: Cytokine and adipokine signaling in uremic cachexia. Nature Clinical Practice. Nephrology. 2: 527-34. PMID 16941045 DOI: 10.1038/Ncpneph0273  0.336
2006 DeBoer MD, Marks DL. Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic disease. Nature Clinical Practice. Endocrinology & Metabolism. 2: 459-66. PMID 16932335 DOI: 10.1038/Ncpendmet0221  0.342
2006 Deboer MD, Marks DL. Cachexia: lessons from melanocortin antagonism. Trends in Endocrinology and Metabolism: Tem. 17: 199-204. PMID 16750633 DOI: 10.1016/J.Tem.2006.05.005  0.353
2006 Mak RH, Cheung W, Cone RD, Marks DL. Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney International. 69: 794-7. PMID 16518340 DOI: 10.1038/Sj.Ki.5000182  0.359
2006 Marks DL, Hruby V, Brookhart G, Cone RD. The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides. 27: 259-64. PMID 16274853 DOI: 10.1016/J.Peptides.2005.01.025  0.303
2005 Scarlett JM, Marks DL. The use of melanocortin antagonists in cachexia of chronic disease Expert Opinion On Investigational Drugs. 14: 1233-1240. PMID 16185165 DOI: 10.1517/13543784.14.10.1233  0.314
2005 Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH. Role of leptin and melanocortin signaling in uremia-associated cachexia. The Journal of Clinical Investigation. 115: 1659-65. PMID 15931394 DOI: 10.1172/Jci22521  0.358
2005 Sartin JL, Wagner CG, Marks DL, Daniel JA, McMahon CD, Obese FY, Partridge C. Melanocortin-4 receptor in sheep: A potential site for therapeutic intervention in disease models Domestic Animal Endocrinology. 29: 446-455. PMID 15919173 DOI: 10.1016/J.Domaniend.2005.02.027  0.342
2005 Markison S, Foster AC, Chen C, Brookhart GB, Hesse A, Hoare SR, Fleck BA, Brown BT, Marks DL. The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonist. Endocrinology. 146: 2766-73. PMID 15774557 DOI: 10.1210/En.2005-0142  0.328
2005 Mak RH, Cheung W, Cone RD, Marks DL. Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. Pediatric Nephrology (Berlin, Germany). 20: 427-31. PMID 15662537 DOI: 10.1007/S00467-004-1789-1  0.35
2004 Wagner CG, McMahon CD, Marks DL, Daniel JA, Steele B, Sartin JL. A role for agouti-related protein in appetite regulation in a species with continuous nutrient delivery Neuroendocrinology. 80: 210-218. PMID 15604600 DOI: 10.1159/000082735  0.3
2004 Fekete C, Marks DL, Sarkar S, Emerson CH, Rand WM, Cone RD, Lechan RM. Effect of Agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse. Endocrinology. 145: 4816-21. PMID 15256492 DOI: 10.1210/En.2004-0476  0.336
2004 Ramos EJ, Suzuki S, Marks D, Inui A, Asakawa A, Meguid MM. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Current Opinion in Clinical Nutrition and Metabolic Care. 7: 427-34. PMID 15192446 DOI: 10.1097/01.Mco.0000134363.53782.Cb  0.322
2004 Marks DL, Boucher N, Lanouette CM, Pérusse L, Brookhart G, Comuzzie AG, Chagnon YC, Cone RD. Ala67Thr polymorphism in the Agouti-related peptide gene is associated with inherited leanness in humans. American Journal of Medical Genetics. Part A. 126: 267-71. PMID 15054840 DOI: 10.1002/Ajmg.A.20600  0.307
2003 Marks D, Cone RD. The role of the melanocortin-3 receptor in cachexia. Annals of the New York Academy of Sciences. 994: 258-66. PMID 12851324 DOI: 10.1111/J.1749-6632.2003.Tb03188.X  0.303
2003 Marks DL, Butler AA, Turner R, Brookhart G, Cone RD. Differential role of melanocortin receptor subtypes in cachexia. Endocrinology. 144: 1513-23. PMID 12639936 DOI: 10.1210/En.2002-221099  0.345
2001 Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 25: S63-7. PMID 11840218 DOI: 10.1038/Sj.Ijo.0801913  0.349
2001 Butler AA, Marks DL, Fan W, Kuhn CM, Bartolome M, Cone RD. Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nature Neuroscience. 4: 605-11. PMID 11369941 DOI: 10.1038/88423  0.349
2001 Marks DL, Cone RD. Central melanocortins and the regulation of weight during acute and chronic disease. Recent Progress in Hormone Research. 56: 359-75. PMID 11237221 DOI: 10.1210/Rp.56.1.359  0.332
1996 Rossmanith WG, Marks DL, Clifton DK, Steiner RA. Induction of galanin mRNA in GnRH neurons by estradiol and its facilitation by progesterone Journal of Neuroendocrinology. 8: 185-191. PMID 8730652 DOI: 10.1046/J.1365-2826.1996.04473.X  0.635
1996 Rossmamth WG, Marks DL, Steiner RA, Clifton DK. Inhibition of steroid-induced galanin mRNA expression in GnRH neurons by specific NMDA-receptor blockade Journal of Neuroendocrinology. 8: 179-184. PMID 8730651 DOI: 10.1046/J.1365-2826.1996.04462.X  0.65
1994 Rossmanith WG, Marks DL, Clifton DK, Steiner RA. Induction of galanin gene expression in gonadotropin-releasing hormone neurons with puberty in the rat Endocrinology. 135: 1401-1408. PMID 7523097 DOI: 10.1210/Endo.135.4.7523097  0.616
1994 Marks DL, Lent KL, Rossmanith WG, Clifton DK, Steiner RA. Activation-dependent regulation of galanin gene expression in gonadotropin-releasing hormone neurons in the female rat Endocrinology. 134: 1991-1998. PMID 7512492 DOI: 10.1210/Endo.134.5.7512492  0.62
1993 Marks DL, Smith MS, Clifton DK, Steiner RA. Regulation of Gonadotropin-Releasing Hormone (GnRH) and galanin gene expression in GnRH neurons during lactation in the rat Endocrinology. 133: 1450-1458. PMID 7689958 DOI: 10.1210/Endo.133.3.7689958  0.616
1993 Marks DL, Smith MS, Vrontakis M, Clifton DK, Steiner RA. Regulation of galanin gene expression in gonadotropin-releasing hormone neurons during the estrous cycle of the rat Endocrinology. 132: 1836-1844. PMID 7681766 DOI: 10.1210/Endo.132.4.7681766  0.611
1993 Steiner RA, Clifton DK, Marks DL, Smith MS. Regulation of gonadotropin-releasing hormone (GnRH) and galanin gene expression in GnRH neurons during lactation in the rat [published erratum appears in Endocrinology 1994 Jan;134(1):498] Endocrinology. 133: 1450-1458. DOI: 10.1210/En.133.3.1450  0.562
1993 Marks D, Bageac A, Clifton D, Steiner R. INDUCTION OF GALANIN GENE EXPRESSION IN GnRH NEURONS WITH PUBERTY IN THE FEMALE RAT Pediatric Research. 33: S32-S32. DOI: 10.1203/00006450-199305001-00174  0.614
1992 Marks DL, Wiemann JN, Burton KA, Lent KL, Clifton DK, Steiner RA. Simultaneous visualization of two cellular mRNA species in individual neurons by use of a new double in Situ hybridization method Molecular and Cellular Neuroscience. 3: 395-405. DOI: 10.1016/1044-7431(92)90051-3  0.598
Show low-probability matches.